Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Biotech
Market Cap: $157.28B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.39 | 0.99%
Avg Daily Range (30 D): $3.79 | 1.30%
Avg Daily Range (90 D): $3.85 | 1.34%
Institutional Daily Volume
Avg Daily Volume: 4.83M
Avg Daily Volume (30 D): 1.86M
Avg Daily Volume (90 D): 2.15M
Trade Size
Avg Trade Size (Sh.): 134
Avg Trade Size (Sh.) (30 D): 38
Avg Trade Size (Sh.) (90 D): 39
Institutional Trades
Total Inst.Trades: 113,061
Avg Inst. Trade: $6.22M
Avg Inst. Trade (30 D): $29.11M
Avg Inst. Trade (90 D): $32.38M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 20
Market Closing Trades
Avg Closing Trade: $64.54M
Avg Closing Trade (30 D): $113.78M
Avg Closing Trade (90 D): $152.53M
Avg Closing Volume: 386.68K
   
News
Jul 22, 2025 @ 7:20 AM
Bispecific Antibodies Market Set to Surge to $163....
Source: Analystview Market Insights
Jul 21, 2025 @ 11:00 AM
NodThera Announces Appointment of Dr. Jyothis Geor...
Source: Nodthera
Jul 16, 2025 @ 8:25 AM
3 Reasons the Schwab U.S. Dividend Equity ETF Is a...
Source: Justin Pope
Jul 15, 2025 @ 8:00 AM
Draig Therapeutics Appoints Experienced Biotech Le...
Source: Mark Swallow, Sandi Greenwood
Jul 10, 2025 @ 8:21 AM
1 Top Dividend Growth Stock to Buy Right Now
Source: Prosper Junior Bakiny
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $3.22 $5.27
Diluted EPS $3.2 $5.22
Revenue $ $ 8.15B $ 8.5B
Gross Profit $ $ 5.18B $ 5.19B
Net Income / Loss $ $ 1.73B $ 2.83B
Operating Income / Loss $ $ 1.18B $ 2.05B
Cost of Revenue $ $ 2.97B $ 3.31B
Net Cash Flow $ $ -3163M $ -290M
PE Ratio